Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance.

MLA

Hodel, Eva Maria, et al. “Residual Antimalarials in Malaria Patients from Tanzania--Implications on Drug Efficacy Assessment and Spread of Parasite Resistance.” PloS One, vol. 4, no. 12, Dec. 2009, p. e8184. EBSCOhost, https://doi.org/10.1371/journal.pone.0008184.

APA

Hodel, E. M., Kabanywanyi, A. M., Malila, A., Zanolari, B., Mercier, T., Beck, H.-P., Buclin, T., Olliaro, P., Decosterd, L. A., & Genton, B. (2009). Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance. PloS One, 4(12), e8184. https://doi.org/10.1371/journal.pone.0008184

Chicago

Hodel, Eva Maria, Abdunoor Mulokozi Kabanywanyi, Aggrey Malila, Boris Zanolari, Thomas Mercier, Hans-Peter Beck, Thierry Buclin, Piero Olliaro, Laurent Arthur Decosterd, and Blaise Genton. 2009. “Residual Antimalarials in Malaria Patients from Tanzania--Implications on Drug Efficacy Assessment and Spread of Parasite Resistance.” PloS One 4 (12): e8184. doi:10.1371/journal.pone.0008184.